The Pistoia Alliance is partnering with the TM Forum (a non-profit ndustry association focused on enabling service provider agility and …
The Pistoia Alliance is signposting the Hierarchical Editing Language for Macromolecules (HELM) developed at Pfizer as a way to solve the problem with how to consistently represent large molecules, such as proteins, peptides, oligonucleotides, and small molecule drugs.
The Pistoia Alliance App Strategy was outlined during a webinar presentation on 9 November. The presentation began with a brief overview of the three proposed phases of the Pistoia Alliance AppStore, and continued on with a lively question and answer session that covered all facets of our strategy and “appification” in life science R&D.
In this entry, I invited Sean to discuss how the app works. The work on ODDT demonstrates the importance of the Pistoia Alliance’s newappification strategy, which aims to make informatics tools accessible to scientists and the broader community interested in using mobile devices to conduct and communicate about science.
One of the great things about mobile apps is that they are low-profile, easy-to-adopt tools that theoretically could remove traditional barriers between information sources.
In my last entry, I posited that technology should NOT be a barrier to “appifying” R&D workflows. So why haven’t apps taken off so far in R&D? I’d argue that it comes down to the paradigm shift that mobile technology has created in computing.
The computing transformation being effected by mobile computing may not be one we fully appreciate while burying our heads and thumbs in the latest cool app or game.
It’s been quite quiet on the Pistoia Alliance blog and website since June, but only because instead of taking holidays, we’ve been working hard developing a number of our nascent workstreams (though I did take a day to watch some of the volleyball at the Olympics—saw some very skillful play!).
The Dragons’ Den session at the Pistoia Alliance Conference last April gave us a chance to socialize some of our embryonic portfolio projects.